Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Invested Capital (2019 - 2025)

Silo Pharma (SILO) has disclosed Invested Capital for 7 consecutive years, with $6.3 million as the latest value for Q4 2025.

  • Quarterly Invested Capital rose 25.25% to $6.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Dec 2025, up 25.25% year-over-year, with the annual reading at $6.3 million for FY2025, 25.25% up from the prior year.
  • Invested Capital hit $6.3 million in Q4 2025 for Silo Pharma, up from $5.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $11.9 million in Q3 2022 to a low of $3.8 million in Q2 2021.
  • Historically, Invested Capital has averaged $7.1 million across 5 years, with a median of $6.5 million in 2024.
  • Biggest five-year swings in Invested Capital: soared 1716.0% in 2021 and later plummeted 47.62% in 2024.
  • Year by year, Invested Capital stood at $9.5 million in 2021, then increased by 12.92% to $10.7 million in 2022, then crashed by 42.3% to $6.2 million in 2023, then dropped by 18.5% to $5.0 million in 2024, then rose by 25.25% to $6.3 million in 2025.
  • Business Quant data shows Invested Capital for SILO at $6.3 million in Q4 2025, $5.0 million in Q3 2025, and $4.9 million in Q2 2025.